Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions

Arthritis and Rheumatism

Volumn 60, Issue 10, 2009, Pages 2966-2977

  Zhang, Ge ^a   Sheng, Hui ^b   He, Yi Xin ^a   Xie, Xin Hui ^a   Wang, Yi Xiang ^a   Lee, Kwong Man ^a   Yeung, Ka Wai ^a   Li, Zi Rong ^c   He, Wei ^d   Griffith, James F ^a   Leung, Kwok Sui ^a   Qin, Ling ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TONGJI UNIVERSITY   (China)

^c Sino Japan Friendship Hospital   (China)

^d GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; VASCULOTROPIN;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE NECROSIS; BONE REMODELING; CELL COUNT; CELL SIZE; CONTROLLED STUDY; FEMUR; HEMATOPOIETIC CELL; MALE; MESENCHYME CELL; MONONUCLEAR CELL; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SURFACE PROPERTY;

ANIMALS; BONE MARROW; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; FEMUR; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; OSTEONECROSIS; RABBITS; SIGNAL TRANSDUCTION; STEM CELLS; STEROIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349776235     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24847     Document Type: Article

References (49)

1. Aaron RK. Osteonecrosis: etiology, pathophysiology and diagnosis. In: Callaghan JJ, Rosenberg AG, Rubash HE, editors. The adult hip. Philadelphia: Lippincott-Raven; 1998. p. 451-466
2. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2003;52:337-355
3. Plenk H Jr, Gstettner M, Grossschmidt K, Breitenseher M, Urban M, Hofmann S. Magnetic resonance imaging and histology of repair in femoral head osteonecrosis. Clin Orthop Relat Res 2001;386:42-53.
4. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002;99:9656-9661
5. Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH. Osteonecrosis of the femoral head: potential treatment with growth and differentiation factors. Clin Orthop Relat Res 1998; 355(Suppl):S314-35.
6. Hershey JC, Baskin EP, Corcoran HA, Bett A, Dougherty NM, Gilberto DB, et al. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 2003;18:142-149 (Pubitemid 36974968)
7. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002;90:966-973 (Pubitemid 34633862)
8. Yang C, Yang S, Du J, Li J, Xu W, Xiong Y. Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit. Chin Med J (Engl) 2003;116:1544-1548 (Pubitemid 37461676)
9. Zhou YF, Stabile E, Walker J, Shou M, Baffour R, Yu Z, et al. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. J Am Coll Cardiol 2004;44:897-903. (Pubitemid 39099591)
10. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9:702-712 (Pubitemid 36749219)
11. Jain RK. Vascular and interstitial biology of tumors. In: Abeloff M, editor. Clinical oncology. New York: Elsevier; 2004. p. 153-172
12. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
13. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005;56:79-101.
14. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004;104:2084-2086 (Pubitemid 39297861)
15. Qin L, Zhang G, Sheng H, Yeung KW, Yeung HY, Chan CW, et al. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone 2006;39:863-871 (Pubitemid 44311715)
16. Zhang G, Qin L, Sheng H, Yeung KW, Yeung HY, Cheung WH, et al. Epimedium-derived phytoestrogen exert beneficial effect on preventing steroid-associated osteonecrosis in rabbits with inhibition of both thrombosis and lipid-deposition. Bone 2007;40: 685-692 (Pubitemid 46187235)
17. Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296-1304 (Pubitemid 38480841)
18. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007. (Pubitemid 41262334)
19. Bogin L, Margalit R, Mispelter J, Degani H. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16:289-299 (Pubitemid 34920428)
20. Hernigou P, Beaujean F. Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J Bone Joint Surg Am 1997;79: 1047-1053 (Pubitemid 27310575)
21. Zhang G, Qin L, Hung WY, Shi YY, Leung PC, Yeung HY, et al. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 2006;38: 818-825 (Pubitemid 44498593)
22. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997;40: 2055-2064 (Pubitemid 27494667)
23. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000; 14:1414-1418 (Pubitemid 30599322)
24. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units: Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2:595-610.
25. Radke S, Battmann A, Jatzke S, Eulert J, Jakob F, Schutze N. Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 2006;24:945-952 (Pubitemid 43804929)
26. Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Niemi M, et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 2002; 160:1393-1403 (Pubitemid 34411643)
27. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005;437:497-504.
28. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 2004;9:509-515 (Pubitemid 39410181)
29. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004;113:885-894 (Pubitemid 38544147)
30. Kim SY, Kim YG, Kim PT, Ihn JC, Cho BC, Koo KH. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am 2005;87:2012-2018
31. Kabata T, Matsumoto T, Yagishita S, Wakayama T, Iseki S, Tomita K. Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment. J Rheumatol 2008;35:2383-2390
32. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-580 (Pubitemid 39658463)
33. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000;156:965-976 (Pubitemid 30626954)
34. Van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999;104:1613-1620 (Pubitemid 30002373)
35. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999;4:915-924 (Pubitemid 30054898)
36. Suzuki O, Bishop AT, Sunagawa T, Katsube K, Friedrich PF. VEGF-promoted surgical angiogenesis in necrotic bone. Microsurgery 2004;24:85-91. (Pubitemid 38174362)
37. Katsube K, Bishop AT, Simari RD, Yla-Herttuala S, Friedrich PF. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J Orthop Res 2005;23:469-474 (Pubitemid 40287877)
38. Hu ZM, Zhou MQ, Gao JM. Effect of vascular endothelial growth factor and tumor necrosis factor receptor for treatment of avascular necrosis of the femoral head in rabbits. Nan Fang Yi Ke Da Xue Xue Bao 2008;28:2177-9. In Chinese.
39. Vadasz Z, Misselevich I, Norman D, Peled E, Boss JH. Localization of vascular endothelial growth factor during the early reparative phase of the rats' vessels deprivation-induced osteonecrosis of the femoral heads. Exp Mol Pathol 2004;77:145-148 (Pubitemid 39209297)
40. Kim HK, Bian H, Randall T, Garces A, Gerstenfeld LC, Einhorn TA. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis. J Bone Miner Res 2004;19:2041-2048 (Pubitemid 41103419)
41. Henriksen K, Karsdal M, Delaisse JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 2003;278:48745-48753 (Pubitemid 41079516)
42. Sipola A, Nelo K, Hautala T, Ilvesaro J, Tuukkanen J. Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro. BMC Musculoskelet Disord 2006;7:56. (Pubitemid 44200611)
43. Feng J, Xu Y, Hu Y. Tetramethylpyrazine inhibition on binding of radiolabeled ligand to VEGFR. Chin Pharmacol Bull 2005;21: 939-42. In Chinese. (Pubitemid 41474764)
44. He W, Zeng Q, Zhang Q, Li Y, Pang Z, Zeng P, et al. Study on correlation between pain grading, stage of necrosis and bone marrow-edema in nontraumatic osteonecrosis of femoral head. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008;22:229-302. In Chinese.
45. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002:14-23. (Pubitemid 36008240)
46. Kinnaird T, Stabile E, Burnett MS, Epstein SE. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 2004;95: 354-363 (Pubitemid 39100453)
47. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94:678-685 (Pubitemid 38387752)
48. Gangji V, Toungouz M, Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005;5: 437-442 (Pubitemid 40593328)
49. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972 (Pubitemid 29335849)